Flint Water

In an effort to give back to our community, MMS colleagues worked with the American Red Cross to deliver water to our neighbors in Flint, Michigan. On Wednesday, March 9, the MMS team was able to deliver 190 cases of water and numerous water filters to over 140 homes.

Many people may have heard of the situation in the Flint through media coverage, but it was a truly different experience being in the city and talking to the residents. The lead contamination has left residents without easy access to clean water. The residents need to use bottled water to not only consume and cook, but also to wash their faces and brush their teeth. This is a task many of us take for granted because we can walk into our bathrooms and turn on the faucet without even a moment’s thought. Delivering water and having the opportunity to speak with the residents made us realize the day-to-day struggles they face. But what was most remarkable to me was how resilient these residents were. They were extremely friendly and eager to chat with us, and upbeat. MMS employee Yashwanth Narayan noted, “People were really happy to see us. Some of us even got warm hugs. “

For me it was particularly difficult to think about the children and elderly residents affected by the tainted water. I spoke to one grandmother who has 3 young grandchildren. She gathers water that is being delivered to her home (by organizations like the American Red Cross) while her son is at work to ensure that her son and grandchildren have a constant supply of clean water. Elderly residents should not have to worry about how they are going to carry cases of water into their homes in order to have clean water, and our team was happy to provide this service to these families.

I am grateful for organizations like the American Red Cross for delivering water directly to homes, and I was proud to be part of the MMS team supporting this great cause.   The leadership team at MMS recognizes that this need is not going away anytime soon, and future opportunities to assist the Flint community are currently being planned.

I found that most residents understood the problems facing them and knew where to get help. There were still some residents that were unaware of the resources available to them such as bottled water, filters, and test kits from their local fire stations.  This shows that there are plenty of other opportunities to help this community by providing additional education and outreach for all Flint residents.  It is easy to forget how fortunate we are to have access to clean water, but we cannot forget about our neighbors in Flint.

This water crisis will not be solved in one day, and the residents need the support of their entire community until their water is safe. In the words of my colleague Satyapal Ingle, “Together we can do a lot.”

Suggested For You

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

perspectives

July 16th, 2024

Key Steps to Successful CMC Authoring of IND and IMPD Submissions

perspectives

July 9th, 2024

Managing RTOR Submissions: How to Run a Successful Race from the Top Line Starting Line

perspectives

July 2nd, 2024

Part 1: RWD Noninterventional Study Design and FDA Engagement Opportunity for Early Stage Oncology

perspectives

June 21st, 2024

Peer-Reviewed Journal Articles: The Crucial Role of Publication in the Pharmaceutical Industry

perspectives

June 14th, 2024

A Structured Approach to Benefit-Risk Assessment Throughout Product Development in the Pharmaceutical Industry

perspectives

June 6th, 2024

Datacise and Diversity in Patient Enrollment: Combining Geospatial and Demographic Data to Aid Site Selection

perspectives

May 29th, 2024

Confined Deferrals in Clinical Trial Applications: Anticipating the Revised EU CTR Transparency Rules

perspectives

May 21st, 2024

Psychedelics and Regulatory Considerations Part II: A Shift in Lexicon and Implications of “Nonmedical Use” On Labelling

perspectives

May 10th, 2024

Psychedelics in Drug Development and Regulatory Considerations Part I: Benefit-Risk

perspectives

April 29th, 2024

Validation of Clinical Dashboards for Decision Making